Related Articles
Inhibition of osteoclastogenesis for periprosthetic osteolysis therapy through the suppression of p38 signaling by fraxetin
Britanin inhibits titanium wear particle‑induced osteolysis and osteoclastogenesis
Desoxyrhapontigenin inhibits RANKL‑induced osteoclast formation and prevents inflammation‑mediated bone loss
Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation
Lipopolysaccharide (LPS) promotes osteoclast differentiation and activation by enhancing the MAPK pathway and COX-2 expression in RAW264.7 cells